These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 7598148)

  • 1. Biological therapies: a novel approach to the treatment of autoimmune disease.
    Fox DA
    Am J Med; 1995 Jul; 99(1):82-8. PubMed ID: 7598148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TNF blockade in rheumatoid arthritis: implications for therapy and pathogenesis.
    Maini RN; Elliott M; Brennan FM; Williams RO; Feldmann M
    APMIS; 1997 Apr; 105(4):257-63. PubMed ID: 9164467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal anti-TNF alpha antibody as a probe of pathogenesis and therapy of rheumatoid disease.
    Maini RN; Elliott MJ; Brennan FM; Williams RO; Chu CQ; Paleolog E; Charles PJ; Taylor PC; Feldmann M
    Immunol Rev; 1995 Apr; 144():195-223. PubMed ID: 7590814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New directions for biological therapy in rheumatoid arthritis.
    Elliott MJ; Maini RN
    Int Arch Allergy Immunol; 1994; 104(2):112-25. PubMed ID: 8199454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?
    Feldmann M; Maini RN
    Annu Rev Immunol; 2001; 19():163-96. PubMed ID: 11244034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anti-CD4 therapy in treatment of rheumatoid arthritis--have the die been cast?].
    Keysser G; Alpermann U; Burmester GR
    Z Rheumatol; 1998 Oct; 57(5):320-5. PubMed ID: 9864838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Monoclonal antibody therapy for rheumatoid arthritis].
    Ishii T; Saeki Y
    Nihon Rinsho; 2002 Mar; 60(3):551-5. PubMed ID: 11904972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pathogenesis of rheumatoid arthritis and the development of therapeutic strategies for the clinical investigation of biologics.
    Panayi GS
    Agents Actions Suppl; 1995; 47():1-21. PubMed ID: 7785487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human anti-mouse antibody response induced by anti-CD4 monoclonal antibody therapy in patients with rheumatoid arthritis.
    Horneff G; Winkler T; Kalden JR; Emmrich F; Burmester GR
    Clin Immunol Immunopathol; 1991 Apr; 59(1):89-103. PubMed ID: 2019013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies to CD4.
    Breedveld FC
    Rheum Dis Clin North Am; 1998 Aug; 24(3):567-78. PubMed ID: 9710887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacokinetics and human anti-mouse antibody response in rheumatoid arthritis patients treated with a chimeric anti-CD4 monoclonal antibody.
    Choy EH; Schantz A; Pitzalis C; Kingsley GH; Panayi GS
    Br J Rheumatol; 1998 Jul; 37(7):801-2. PubMed ID: 9714366
    [No Abstract]   [Full Text] [Related]  

  • 12. Rescue of DMARD failures by means of monoclonal antibodies or biological agents.
    Kalden JR
    Clin Exp Rheumatol; 1997; 15 Suppl 17():S91-8. PubMed ID: 9266139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-tumor necrosis factor-alpha monoclonal antibody therapy for rheumatoid arthritis.
    Kavanaugh AF
    Rheum Dis Clin North Am; 1998 Aug; 24(3):593-614. PubMed ID: 9710889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functions of interleukin-34 and its emerging association with rheumatoid arthritis.
    Zhou RP; Wu XS; Xie YY; Dai BB; Hu W; Ge JF; Chen FH
    Immunology; 2016 Dec; 149(4):362-373. PubMed ID: 27550090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-CD4 treatment of patients with rheumatoid arthritis. Is there still a place for this treatment principle in RA?
    Kalden JR
    Clin Exp Rheumatol; 1994; 12 Suppl 11():S67-9. PubMed ID: 7768057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New approaches to the therapy of autoimmune diseases: rheumatoid arthritis as a paradigm.
    Moreland LW; Heck LW; Sullivan W; Pratt PW; Koopman WJ
    Am J Med Sci; 1993 Jan; 305(1):40-51. PubMed ID: 8416681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New immunologic treatment of rheumatoid arthritis].
    Sany J
    Rev Rhum Ed Fr; 1993 Mar; 60(3):229-39. PubMed ID: 8293009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergy between anti-CD4 and anti-tumor necrosis factor in the amelioration of established collagen-induced arthritis.
    Williams RO; Mason LJ; Feldmann M; Maini RN
    Proc Natl Acad Sci U S A; 1994 Mar; 91(7):2762-6. PubMed ID: 7908442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic effects of interleukin-1β and interleukin-17A antibodies on collagen-induced arthritis mouse model.
    Zhang Y; Ren G; Guo M; Ye X; Zhao J; Xu L; Qi J; Kan F; Liu M; Li D
    Int Immunopharmacol; 2013 Feb; 15(2):199-205. PubMed ID: 23280345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TNF alpha blockade in rheumatoid arthritis: rationale, clinical outcomes and mechanisms of action.
    Elliott MJ; Feldmann M; Maini RN
    Int J Immunopharmacol; 1995 Feb; 17(2):141-5. PubMed ID: 7544768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.